三重阴性乳腺癌的治疗环境
Yi Hu1, Chen Wang1, Huishi Liang1
1Beijing Key Laboratory of Gene Resource and Molecular Development, Beijing Normal University, Beijing, China.
Medical oncology (Northwood, London, England)
|August 29, 2024
概括
三重阴性乳腺癌 (TNBC) 是具有侵略性和异质性的. 本综述探讨了TNBC亚型,当前的疗法和针对瘤微环境的新策略,以提高免疫疗法疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 三阴性乳腺癌 (TNBC) 的特点是具有侵略性的生物行为和显著的分子异质性.
- 了解TNBC亚型对于开发有效的向疗法至关重要.
- 现有的FDA批准的治疗方法包括PI3K/AKT/mTOR抑制剂,PARP抑制剂和抗体-药物联合体.
研究的目的:
- 审查目前用于分类TNBC亚型的方法.
- 讨论TNBC治疗策略的不断变化的格局.
- 通过考虑瘤微环境和免疫疗法,提出新的治疗途径.
主要方法:
- 对TNBC研究的综合文献综述.
- 分析当前和新兴的治疗药物和策略.
- 探索瘤微环境在TNBC进展和治疗反应中的作用.
主要成果:
- 由于TNBC具有很高的异质性,因此需要针对亚型进行特定的治疗.
- 有针对性的疗法和创新方法,如类策略,显示出有前途.
- 瘤微环境是提高免疫治疗疗效的关键领域.
结论:
- 根据TNBC亚型和分子特征量身定制治疗策略至关重要.
- 对瘤微环境的进一步研究可以打开新的治疗可能性.
- 将免疫疗法与其他疗法结合起来,有可能改善患者的治疗结果.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
